LISA WARREN: Open Payments
NPI 1184945289 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 34 payments from 18 companies in 2025. Trend: 2023 $723 · 2024 $1,196 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $174 |
| Novo Nordisk Inc | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Lilly USA, LLC | 3 | $57 |
| ACADIA Pharmaceuticals Inc | 2 | $42 |
| Insmed, Inc. | 2 | $39 |
| PFIZER INC. | 1 | $27 |
| UCB, Inc. | 1 | $26 |
| Viatris Specialty LLC | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
Products named: AIRSUPRA, REXULTI, BREZTRI, NUPLAZID, Arikayce, MOUNJARO, XELJANZ, Bimzelx.
Industry payments across TN — which companies pay providers there.
